Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Expanded Access Listings

You can search in free text – simply type the disease, drug, company name, or other detail into the Search bar below and click Apply
Displaying 220 of 488

PharmaMar

EA Page: http://pharmamar.com/patients/oncological-areas/?lang=en

Celularity Inc.

Incyte, Inc.

RedHill Biopharma Ltd

EA Page: https://www.redhillbio.com/expandedaccess

Taiho Oncology, Inc

EA Page: https://www.taihooncology.com/us/science/expanded-access/

Exelixis, Inc.

EA Page: https://www.exelixis.com/access-to-investigational-therapies/

Pharvaris

EA Page: https://pharvaris.com/patients/

Oblato, Inc.

EA Page: https://oblatoinc.com/clinical-trials/#eap

Oneness Biotech Company Limited

EA Page: https://www.onenessbio.com.tw/en/home_01.php?p=2&a=183

Reneo Pharmaceuticals Inc.

EA Page: https://reneopharma.com/programs/

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Current page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • …
  • Next page ››
  • Last page Last »

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA